Kenvue stock cheered in Wall Street debut, as Tylenol and Band-Aid brand parent is valued at $48 billion

Kenvue's stock was cheered in its Wall Street debut Thursday, as the J&J spinoff saw its stock open 16.0% above where the initial public offering was priced.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.